Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.
North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.
In 2019, the market size of Continuous Blood Glucose Monitoring is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Continuous Blood Glucose Monitoring.
This report studies the global market size of Continuous Blood Glucose Monitoring, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Continuous Blood Glucose Monitoring production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
Lifescan
Medtronic
Bayer AG
Abbott
Terumo
Dexcom
Echo Therapeutics
B. Braun Melsungen
Arkray
Cellnovo Group
Nemaura
Tandem Diabetes Care
Market Segment by Product Type
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Market Segment by Application
Hospitals
Clinics
Home Care
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Continuous Blood Glucose Monitoring status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Continuous Blood Glucose Monitoring manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Continuous Blood Glucose Monitoring are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Continuous Blood Glucose Monitoring . Industry analysis & Market Report on Continuous Blood Glucose Monitoring is a syndicated market report, published as Global (United States, European Union and China) Continuous Blood Glucose Monitoring Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Continuous Blood Glucose Monitoring market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.